AS

Asha Singh

Active Director Director DIN 07240934
DIN 07240934 First appointment Jul 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2015
Shareholding value •••• Premium profile

About Asha Singh

Data last updated:

Asha Singh is a Director at Godbless Pharma Private Limited (since 2015). The company operates in Pharma. Godbless Pharma Private Limited reported revenue of ₹65.8 Lakh (FY 2020).

DIN 07240934
Primary Designation Director
Industry Pharma
First Appointment 17 Jul 2015
Oldest Company Age 13 yrs
Largest company Godbless Pharma Private Limited · ₹65.8 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Godbless Pharma Private Limited U24233UP2013PTC058916
Director17 Jul 20152013₹65.8 Lakh (FY 2020)Active

Board colleagues of Asha Singh

Directorship timeline

Open interactive timeline →
Godbless Pharma Private Limited
Premium access

Shareholding and investment profile for Asha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asha Singh

Asha Singh currently holds 1 directorship: Godbless Pharma Private Limited (Director, since 17 Jul 2015, revenue ₹65.8 Lakh (FY 2020)).

Asha Singh was first appointed on 17 Jul 2015 as Director at Godbless Pharma Private Limited.

The current boards of Asha Singh's companies include Dilip Kumar Singh (Godbless Pharma Private Limited), Kameshwar Prasad Srivastava (Godbless Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available